Symptomatic response to GERDOFF ® in patients with gastro-esophageal reflux disease and poor response to alginates: an exploratory, post-market, open-label study.

CONCLUSION: GERDOFF® could effectively treat GER symptoms in patients not responding to PPI or alginate-based formulation. ISRCTN_15143752. PMID: 32721918 [PubMed - in process]
Source: The Turkish Journal of Gastroenterology - Category: Gastroenterology Authors: Tags: Turk J Gastroenterol Source Type: research